ARS PHARMACEUTICALS, INC.

Insiders ARS Pharmaceuticals, Inc.

Equities

SPRY

US82835W1080

Market Closed - Nasdaq Other stock markets 16:00:00 2024-05-14 EDT			5-day change	1st Jan Change
8.98 ^USD	+1.01%		-5.17%	+63.87%

05-09	ARS Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-30	ARS Pharmaceuticals, Inc. Submits Response for Neffy (Epinephrine Nasal Spray) Marketing Authorization Application to EMA's Chmp	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

ARS Pharmaceuticals Insider Sold Shares Worth $928,005, According to a Recent SEC Filing	04-18	MT
ARS Pharmaceuticals Insider Sold Shares Worth $928,005, According to a Recent SEC Filing	04-18	MT
Ars Pharmaceuticals Insider Sold Shares Worth $927,735, According to a Recent SEC Filing	04-10	MT
Ars Pharmaceuticals Insider Bought Shares Worth $319,954, According to a Recent SEC Filing	23-10-02	MT
Rate Hike Pause Hopes Boost Exchange-Traded Funds, Equity Futures Premarket Wednesday	23-09-20	MT
Insider Buy: Ars Pharmaceuticals	23-08-31	MT
Insider Sell: Ars Pharmaceuticals	23-08-07	MT
Insider Sell: ARS Pharmaceuticals	23-06-05	MT
Insider Sell: Ars Pharmaceuticals	23-05-10	MT
ARS Pharmaceuticals, Inc. Appoints Brian T. Dorsey as Chief Operations Officer	22-12-09	CI
Silverback Therapeutics, Inc. Announces Executive Changes	22-09-02	CI
Silverback Therapeutics, Inc. Announces Thilo Schroeder Will Not Stand for Re-Election as Member of the Company Board of Directors	22-03-17	CI
Silverback Therapeutics Announces the Appointment of Dr. Maria Koehler to Its Board of Directors	21-03-15	CI
Silverback Therapeutics, Inc. Appoints Jonathan Piazza as Chief Financial Officer	20-11-10	CI
Silverback Therapeutics, Inc. Appoints Andrew Powell as Director	20-11-10	CI
Silverback Therapeutics, Inc. Announces Executive Promotions	20-09-24	CI
Silverback Therapeutics Appoints Vickie L. Capps to Board of Directors and Audit Committee Chair	20-06-04	CI
Silverback Therapeutics, Inc. Appoints Laura Shawver as President and CEO	20-04-22	CI
Silverback Therapeutics Announces Board Changes	20-03-11	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW